In the latest issue of the journal Cell (Cell 143, 686-693), MRC Protein Phosphorylation Unit Director Sir Philip Cohen gives his perspective on whether components of the ubiquitin system will become as important drug targets as protein kinases for the pharmaceutical industry in the future. To read his article "Will the ubiquitin system furnish as many drug targets as protein kinases" click here